Flt3 ligand and conjugation to IL-1 peptide as adjuvants for a type 1, T-cell response to an HIV p17 gag vaccine

Author： Pisarev V.M.   Parajuli P.   Mosley R.L.   Chavez J.   Zimmerman D.   Winship D.   Talmadge J.E.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.20, Iss.17, 2002-05, pp. : 2358-2368

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Induction of a cytotoxic T-cell response to HIV-1 proteins with short synthetic peptides and human compatible adjuvants

By Peter K.   Men Y.   Pantaleo G.   Gander B.   Corradin G.  

Vaccine, Vol. 19, Iss. 30, 2001-07 ,pp. : 4121-4129

Elsevier

Access to resources Recommend Favorite

Comparison of the effect of different immunological adjuvants on the antibody and T-cell response to immunization with MUC1-KLH and GD3-KLH conjugate cancer vaccines

By Kim S.K.   Ragupathi G.   Musselli C.   Choi S.-J.   Park Y.S.   Livingston P.O.  

Vaccine, Vol. 18, Iss. 7, 1999-11 ,pp. : 597-603

Elsevier

Access to resources Recommend Favorite

Immunogenicity of an HIV-1 gag DNA vaccine carried by attenuated Shigella

By Xu F.   Hong M.   Ulmer J.B.  

Vaccine, Vol. 21, Iss. 7, 2003-01 ,pp. : 644-648

Elsevier

Access to resources Recommend Favorite

Effect of immunological adjuvant combinations on the antibody and T-cell response to vaccination with MUC1-KLH and GD3-KLH conjugates

By Kim  

Vaccine, Vol. 19, Iss. 4, 2000-10 ,pp. : 530-537

Elsevier

Access to resources Recommend Favorite

IL-15 expression plasmid enhances cell-mediated immunity induced by an HIV-1 DNA vaccine

By Xin K.-Q.   Hamajima K.   Sasaki S.   Tsuji T.   Watabe S.   Okada E.   Okuda K.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 858-866

Elsevier

Access to resources Recommend Favorite